Latest Continuous Disclosure News

humm Group has granted The Abercrombie Group limited access for due diligence following a $0.58 per share indicative acquisition proposal, signaling a cautious but significant step forward in potential ownership change.

Lumos Diagnostics has voluntarily suspended its ASX trading pending a market announcement about strategic agreements, signaling potential shifts in its business trajectory.

G8 Education faces ASX scrutiny over its handling of sensitive information about a former employee, with the regulator questioning the company’s disclosure practices despite GEM’s insistence of compliance.

Bowen Coking Coal Limited has had its ASX trading suspension lifted following its disclosure on funding efforts amid challenging market conditions. The company confirmed compliance with ASX rules, paving the way for immediate reinstatement.

Bowen Coking Coal Limited (BCB) has responded to ASX inquiries about its liquidity challenges, working capital needs from transitioning to an owner-operator model, and deteriorating operating margins, affirming compliance and financial viability despite market pressures.

Trigg Minerals has withdrawn previously reported mineral resource estimates for its Antimony Canyon Project after ASX compliance review, while reaffirming confidence in ongoing exploration efforts.

Alterity Therapeutics has responded to an ASX inquiry about its recent share price and volume spike, confirming no undisclosed information but highlighting imminent clinical data releases and investor roadshows as possible drivers.

BMG Resources has addressed ASX concerns over the timing and disclosure of assay results from its Abercromby Gold Project drill program, confirming compliance with listing rules despite delays and data inconsistencies.

Invion Limited’s IVXO securities have been suspended from ASX quotation due to non-compliance with key listing rules, raising questions about the company’s regulatory standing and investor confidence.

Argosy Minerals has completed a $2 million capital raising led by Evolution Capital, following an ASX inquiry into recent trading activity. The company affirmed the materiality of the placement and its compliance with continuous disclosure rules.

AML3D Limited has confirmed it complied with ASX continuous disclosure rules regarding its recent Letter of Intent with the US Navy, clarifying the timing of its awareness and announcement.

Hydralyte USA has completed its Rights Issue by placing 5 million shortfall shares, raising a total of $608,878 before costs. The move finalizes the company’s recent capital raising efforts under full regulatory compliance.